Anbio Biotechnology (NNNN) Current Assets (2023 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Current Assets of $30.2 million for Q4 2025, up 63.17% year-over-year from $18.5 million in Q4 2024, and down 100.0% quarter-over-quarter from $27680.6 billion in Q2 2025.
Anbio Biotechnology (NNNN) Current Assets (2023 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Current Assets for 3 consecutive years, with $30.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets rose 63.17% year-over-year to $30.2 million; the TTM figure through Dec 2025 stood at $30.2 million (up 63.17% YoY), while the FY2025 annual figure was $30.2 million, up 63.17% from the prior year.
- Current Assets slipped to $30.2 million in Q4 2025 per NNNN's latest filing, from $27680.6 billion in the prior quarter.
- Across five years, Current Assets topped out at $27680.6 billion in Q2 2025 and bottomed at $15.7 million in Q4 2023.
- Historically, Current Assets has averaged $6920.2 billion across 3 years, with a median of $24.4 million in 2024.
- Annual changes were most pronounced in 2024 — Current Assets rose 17.68% — and 2025, when it jumped 63.17%.
- Anbio Biotechnology's Current Assets stood at $15.7 million in 2023, then increased by 17.68% to $18.5 million in 2024, then surged by 63.17% to $30.2 million in 2025.
- Business Quant data shows NNNN's Current Assets at $30.2 million in Q4 2025, $27680.6 billion in Q2 2025, and $18.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.68 Bn | 129.47 Bn | 1.96 Bn | 9.54 Bn |
| 2 | Becton Dickinson | 52.46 Bn | 51.59 Bn | 2.32 Bn | 8.14 Bn |
| 3 | Alcon | 35.84 Bn | 34.49 Bn | 1.68 Bn | 6.62 Bn |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 4.32 Bn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 11.74 Bn |
| 6 | West Pharmaceutical Services | 25.14 Bn | 24.71 Bn | 329.20 Mn | 1.81 Bn |
| 7 | Solventum | 15.35 Bn | 14.95 Bn | 1.29 Bn | 3.74 Bn |
| 8 | Cooper Companies | 14.90 Bn | 14.77 Bn | 735.40 Mn | 2.30 Bn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | 6.99 Bn |
| 10 | Anbio Biotechnology | 303.08 Mn | 291.18 Mn | - | 30.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.24 Mn |
| Jun 30, 2025 | 27,680.59 Bn |
| Dec 31, 2024 | 18.53 Mn |
| Dec 31, 2023 | 15.75 Mn |